1090 CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT

✍ Scribed by Tombal, B.; Oudard, S.; Ozguroglu, M.; Hansen, S.; Kocak, I.; Gravis, G.; Sartor, A.O.; Shen, L.; de Bono, J.S.

• Book ID: 123581779
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 262 KB
• Volume: 10
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(11)61069-5